EW — Edwards Lifesciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual balance sheet for Edwards Lifesciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1,467	1,215	1,645	3,976	4,226
Net Total Accounts Receivable
Net Total Receivables	665	699	837	727	912
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	3,181	3,096	4,036	6,285	6,739
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1,639	1,725	1,843	1,784	1,915
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	8,503	8,293	9,363	13,055	13,697
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	1,032	1,022	1,195	1,505	1,814
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	2,667	2,486	2,713	3,057	3,360
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	5,836	5,807	6,650	9,998	10,338
Total Liabilities & Shareholders' Equity	8,503	8,293	9,363	13,055	13,697
Total Common Shares Outstanding